Eric Warren - 14 Mar 2023 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role: Chief Commercial Officer
Signature: /s/ Sheldon L. Koenig, by power of attorney
Issuer symbol: ESPR
Transactions as of: 14 Mar 2023
Transactions value $: $0
Form type: 4
Filing time: 15 Mar 2023, 09:22:37 UTC
Previous filing: 08 Mar 2023
Next filing: 20 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ESPR	Common Stock	Award	$0	+22.3K	+45.91%	$0.00	70.9K	14 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ESPR	Stock Option (right to buy)	Award	$0	+94.5K		$0.00	94.5K	14 Mar 2023	Common Stock	94.5K	$4.02	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Such award will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.
F2	Such options will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.